Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 301.49 Million MYR | -47.59% |
| 2022 | 575.26 Million MYR | -49.75% |
| 2021 | 1.14 Billion MYR | 115.69% |
| 2020 | 530.72 Million MYR | -15.74% |
| 2019 | 629.89 Million MYR | 23.95% |
| 2018 | 508.18 Million MYR | 60.93% |
| 2017 | 315.77 Million MYR | 19.76% |
| 2016 | 263.67 Million MYR | 4.59% |
| 2015 | 252.11 Million MYR | 21.57% |
| 2014 | 207.37 Million MYR | -5.6% |
| 2013 | 219.68 Million MYR | 22.43% |
| 2012 | 179.44 Million MYR | 2.23% |
| 2011 | 175.53 Million MYR | 4.79% |
| 2010 | 167.51 Million MYR | 40.7% |
| 2009 | 119.05 Million MYR | -24.54% |
| 2008 | 157.76 Million MYR | 30.11% |
| 2007 | 121.25 Million MYR | 18.61% |
| 2006 | 102.23 Million MYR | 62.98% |
| 2005 | 62.72 Million MYR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 351.23 Million MYR | 4.38% |
| 2024 Q1 | 286.97 Million MYR | -4.82% |
| 2024 Q2 | 336.48 Million MYR | 17.25% |
| 2023 Q2 | 406.69 Million MYR | -10.94% |
| 2023 Q1 | 456.63 Million MYR | -20.62% |
| 2023 Q3 | 330.06 Million MYR | -18.84% |
| 2023 FY | 301.49 Million MYR | -47.59% |
| 2023 Q4 | 301.49 Million MYR | -8.66% |
| 2022 Q3 | 744.51 Million MYR | -15.35% |
| 2022 FY | 575.26 Million MYR | -49.75% |
| 2022 Q1 | 997.03 Million MYR | -12.9% |
| 2022 Q4 | 575.26 Million MYR | -22.73% |
| 2022 Q2 | 879.47 Million MYR | -11.79% |
| 2021 Q2 | 856.79 Million MYR | 31.42% |
| 2021 Q4 | 1.14 Billion MYR | -4.85% |
| 2021 FY | 1.14 Billion MYR | 115.69% |
| 2021 Q3 | 1.2 Billion MYR | 40.42% |
| 2021 Q1 | 651.96 Million MYR | 22.84% |
| 2020 FY | 530.72 Million MYR | -15.74% |
| 2020 Q1 | 603.14 Million MYR | -4.25% |
| 2020 Q3 | 515.35 Million MYR | -16.69% |
| 2020 Q4 | 530.72 Million MYR | 2.98% |
| 2020 Q2 | 618.56 Million MYR | 2.56% |
| 2019 Q4 | 629.89 Million MYR | 8.85% |
| 2019 FY | 629.89 Million MYR | 23.95% |
| 2019 Q1 | 502.03 Million MYR | -1.21% |
| 2019 Q3 | 578.68 Million MYR | 8.58% |
| 2019 Q2 | 532.96 Million MYR | 6.16% |
| 2018 Q1 | 294.25 Million MYR | -6.82% |
| 2018 Q4 | 508.18 Million MYR | 14.23% |
| 2018 Q3 | 444.86 Million MYR | 38.11% |
| 2018 FY | 508.18 Million MYR | 60.93% |
| 2018 Q2 | 322.11 Million MYR | 9.47% |
| 2017 Q2 | 322.79 Million MYR | 17.1% |
| 2017 Q1 | 275.66 Million MYR | 4.54% |
| 2017 Q3 | 312.25 Million MYR | -3.27% |
| 2017 FY | 315.77 Million MYR | 19.76% |
| 2017 Q4 | 315.77 Million MYR | 1.13% |
| 2016 FY | 263.67 Million MYR | 4.59% |
| 2016 Q4 | 263.67 Million MYR | 11.36% |
| 2016 Q3 | 236.78 Million MYR | 0.49% |
| 2016 Q2 | 235.63 Million MYR | 3.42% |
| 2016 Q1 | 227.84 Million MYR | -9.62% |
| 2015 Q3 | 199.67 Million MYR | -1.49% |
| 2015 FY | 252.11 Million MYR | 21.57% |
| 2015 Q1 | 194.68 Million MYR | -6.12% |
| 2015 Q2 | 202.7 Million MYR | 4.12% |
| 2015 Q4 | 252.11 Million MYR | 26.26% |
| 2014 Q1 | 213.86 Million MYR | -2.65% |
| 2014 Q3 | 198.15 Million MYR | -9.26% |
| 2014 Q2 | 218.36 Million MYR | 2.1% |
| 2014 FY | 207.37 Million MYR | -5.6% |
| 2014 Q4 | 207.37 Million MYR | 4.65% |
| 2013 Q4 | 219.68 Million MYR | 7.46% |
| 2013 Q2 | 198.11 Million MYR | 6.57% |
| 2013 Q1 | 185.89 Million MYR | 3.6% |
| 2013 FY | 219.68 Million MYR | 22.43% |
| 2013 Q3 | 204.43 Million MYR | 3.19% |
| 2012 FY | 179.44 Million MYR | 2.23% |
| 2012 Q3 | 198.6 Million MYR | 3.12% |
| 2012 Q2 | 192.59 Million MYR | 0.0% |
| 2012 Q4 | 179.44 Million MYR | -9.65% |
| 2011 Q4 | 175.53 Million MYR | 0.0% |
| 2011 FY | 175.53 Million MYR | 4.79% |
| 2010 FY | 167.51 Million MYR | 40.7% |
| 2009 FY | 119.05 Million MYR | -24.54% |
| 2008 FY | 157.76 Million MYR | 30.11% |
| 2007 FY | 121.25 Million MYR | 18.61% |
| 2006 FY | 102.23 Million MYR | 62.98% |
| 2005 FY | 62.72 Million MYR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -225184.505% |
| Ansell Limited | 457.04 Million USD | 34.033% |
| Ansell Limited | 457.9 Million USD | 34.157% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -595.723% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -1080918.286% |
| Psykey, Inc. | 49.94 Thousand USD | -603616.46% |
| ConvaTec Group Plc | 395.54 Million USD | 23.776% |
| ConvaTec Group Plc | 396.1 Million USD | 23.884% |
| Encision Inc. | 1.4 Million USD | -21399.524% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 3244085.367% |
| LifePoint, Inc. | 2.3 Million USD | -12955.488% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -12446.65% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -68266.44% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -328033.911% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -30908.76% |
| SmileDirectClub, Inc. | 49.87 Million USD | -504.515% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 14.287% |
| SheerVision, Inc. | 339.66 Thousand USD | -88663.274% |
| United Health Products, Inc. | 33.59 Thousand USD | -897262.938% |
| Vasamed, Inc. | 449.02 Thousand USD | -67044.142% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -3524108.065% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -93482.02% |